SINGU Acquires Synbiotix

• Content
• Building Services
• SINGU Acquires Synbiotix

06 February 2026 | Updated 05 February 2026

SINGU, a provider of cloud-based software for property operations and facility management has acquired UK-based Synbiotix.

The acquisition strengthens SINGU’s presence in the UK and expands its healthcare capabilities, with a particular focus on supporting the operational and regulatory needs of the UK’s National Health Service.

Synbiotix is an established provider of specialised software solutions for the management of healthcare facilities with a focus on catering, compliance, infection prevention and control (IPC), as well as audit and governance processes. Its solutions support healthcare organisations in managing regulatory requirements efficiently, reducing operational risk and improving patient safety.

This acquisition gives SINGU a critical healthcare-specific component to add to its building operations platform, which complements the existing Micad solutions.

Following SINGU’s acquisition of Micad in 2025, which expanded its space and asset management capabilities, the addition of Synbiotix further strengthens the Group’s IFM offering. Together, these solutions enable healthcare organisations to manage facilities, catering, and operational requirements through a single, coordinated technological environment.

Synbiotix will continue to operate within the SINGU Group, ensuring continuity for existing customers. The integration of platforms will aim to support seamless operations across more than 200 NHS Trusts and many other clients.

The acquisition of Synbiotix forms part of SINGU’s continued growth strategy in Europe and underlines the strategic importance of the healthcare sector to the Group. It follows SINGU’s acquisition of Micad and net-haus in 2025 and reflects a targeted buy-and-build approach aimed at creating a vertically integrated platform for mission-critical applications across property operations. 

Paweł Malon, Group CEO, said: “The acquisition of Synbiotix significantly strengthens our position in the healthcare market and further establishes SINGU as a leading European provider of property operations software. We are committed to building an integrated, end-to-end platform that drives value across complex property operations. I look forward to working with Mark Edell and his team to drive operational excellence and improve patient experience.”

Mark Edell, Managing Director of Synbiotix said: “Joining SINGU represents a strategic milestone for Synbiotix. We contribute deep healthcare expertise and many years of experience working with the NHS, while benefiting from the technological strength and scalability of the SINGU platform. This combination creates new opportunities to further develop our solutions and deliver even greater value to healthcare organisations.”

Picture: An image announcing SINGU's acquisition of Synbiotix.

Article written by Dave Mapps | Published 06 February 2026

Share

---

---

Related Articles

---